Accelovance Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Accelovance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010839
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization’s CRO services include protocol development, project management, clinical trial monitoring, biostatistics, medical writing, data management, and pharmacovigilance services. Accelovance’s clinical call center services comprise surveillance programs, patient-reported outcomes, observational studies, site support services, recruitment, patient market research, and other services. Accelovance provides CRO services to pharmaceutical companies, CROs, biotechs and academic institutions. The company operates in the US, the UK, Israel, Russia, and China. Accelovance is headquartered in Rockville, Maryland, the US.

Accelovance Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accelovance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Accelovance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Accelovance Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Immunicum Enters into Agreement with Accelovance and Midwest Melanoma Partnership 10
Accelovance Enters into Partnership with FHI 360 11
Accelovance and Midwest Melanoma Partnership Enters into Agreement 12
Acquisition 13
Accelovance Acquires CRO Business of THERAMetrics 13
Accelovance Acquires Clinquest and Clinquest Services from Clinquest Group 14
Accelovance Acquires Altair Clinical 15
Accelovance Acquires Radiant Development, Contract Research Organization 16
Accelovance Inc – Key Competitors 17
Accelovance Inc – Key Employees 18
Accelovance Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Accelovance Inc, Pharmaceuticals & Healthcare, Key Facts 2
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accelovance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accelovance Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Accelovance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Immunicum Enters into Agreement with Accelovance and Midwest Melanoma Partnership 10
Accelovance Enters into Partnership with FHI 360 11
Accelovance and Midwest Melanoma Partnership Enters into Agreement 12
Accelovance Acquires CRO Business of THERAMetrics 13
Accelovance Acquires Clinquest and Clinquest Services from Clinquest Group 14
Accelovance Acquires Altair Clinical 15
Accelovance Acquires Radiant Development, Contract Research Organization 16
Accelovance Inc, Key Competitors 17
Accelovance Inc, Key Employees 18
Accelovance Inc, Other Locations 19
Accelovance Inc, Subsidiaries 20

★海外企業調査レポート[Accelovance Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Alcazar Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary Alcazar Energy Ltd (Alcazar Energy) is a renewable energy company that acquires, develops and operates power generation projects using solar photovoltaic (PV) and onshore wind technologies. The company offers services such as business development, asset management, investment and financing, …
  • Merus Labs International Inc (MSL):企業の財務・戦略的SWOT分析
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Pulai Group:企業の戦略・SWOT・財務分析
    Pulai Group - Strategy, SWOT and Corporate Finance Report Summary Pulai Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Scripps Research Institute:企業のM&A・事業提携・投資動向
    The Scripps Research Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Scripps Research Institute Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Patanjali Ayurved Ltd:企業の戦略的SWOT分析
    Patanjali Ayurved Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Vitasoy International Holdings Limited (345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Limited (345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • British American Tobacco p.l.c.:戦略・SWOT・企業財務分析
    British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • NOJA Power Switchgear Pty Ltd:企業の戦略的SWOT分析
    NOJA Power Switchgear Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Saft Groupe SA-エネルギー分野:企業M&A・提携分析
    Summary Saft Groupe SA (Saft), a subsidiary of Total SA, is a designer, developer, and manufacturer of batteries. The company provides non-rechargeable and rechargeable batteries thorough nickel, primary lithium, lithium-ion, and other technologies. It offers systems integration, and various turnkey …
  • The TJX Companies, Inc.:企業の戦略・SWOT・財務情報
    The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Noor Takaful:企業の戦略・SWOT・財務情報
    Noor Takaful - Strategy, SWOT and Corporate Finance Report Summary Noor Takaful - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • McConnell Dowell Corp Ltd:企業の戦略的SWOT分析
    McConnell Dowell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mesa Air Group, Inc.:企業の戦略・SWOT・財務分析
    Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mesa Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SignPath Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SignPath Pharma Inc (SignPath) is a developer of therapeutics based on its pure synthesized curcumin compounds. The company’s curcumin compounds acts as an anti-oxidant, anti-inflammatory and anti-cell recycling agent. It develops curcumin based products in different intravenous nanoparticle …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Mitsui Fudosan Co., Ltd.:企業の戦略・SWOT・財務分析
    Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Formosa Laboratories Inc (4746):製薬・医療:M&Aディール及び事業提携情報
    Summary Formosa Laboratories Inc (Formosa Laboratories) is a producer of active pharmaceutical ingredients and UV-filters. The company’s active pharmaceutical ingredients include cholesterol and phosphate binders, anticancers, CNS agents, immunomodulators, MRI enhancing agents, anti-inflammatory and …
  • Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition ( …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆